We have located links that may give you full text access.
A bladder pressure management system for myelodysplasia--clinical outcome.
Journal of Urology 1988 December
A program for the management of neurogenic bladder in patients with myelodysplasia was instituted in July 1983. Of the 114 patients entered into the program who have been followed for a minimum of 18 months 42 per cent required treatment for high intravesical pressures. None of this group or the larger group with low bladder pressures showed progressive upper urinary tract deterioration. In 8 children (17 per cent of those with high pressure bladder dysfunction) high intravesical pressure persisted despite anticholinergic medication and intermittent catheterization, and they required an operation to achieve a low pressure bladder. These results confirm the findings in other studies that about 40 per cent of myelodysplastic children are at high risk for the development of upper tract changes, and that approximately 6 to 8 per cent will not respond sufficiently to anticholinergic agents and intermittent catheterization.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app